Taking a deeper dive into our recent POV, Content Velocity: Mastering the Three Pillars of Success, Angela Tenuta, President, Agency, covers how pharmaceutical companies can master content velocity to deliver brand content with unparalleled speed, precision and reach in pharmaphorum’s most recent Deep Dive Magazine.
In the fast-paced world of life sciences, delivering relevant, personalized content quickly is crucial. Yet, many marketers misunderstand content velocity, thinking it’s just about speeding up content creation or using a single AI tool. True content velocity balances creation, review, and distribution, leveraging human expertise and evolving workflows to meet the unique demands of the pharmaceutical industry.
Angela delves into how pharmaceutical companies can master content velocity to deliver brand content with unparalleled speed, precision, and reach.
Redefining Content Velocity: Beyond Just Speed
Since 2021, EVERSANA INTOUCH has focused on understanding content velocity. It’s not just about quick content creation; it involves the entire supply chain—from ideation and creation to review, approval, and distribution. Optimizing content velocity means ensuring all these components work seamlessly together.
The Three Pillars of Content Velocity
- Crafting Content With Purpose: In pharma, it’s not just about producing content; it’s about making it personalized, relevant, and timely. EVERSANA INTOUCH adapts advanced technology to meet compliance standards, enabling scalable and personalized content creation.
- Navigating the Content Approval Process: Content review ensures accuracy and compliance, but it can be challenging. AI-powered solutions can streamline this process, reducing manual input and enhancing efficiency.
- Distributing Content With Precision: Effective distribution ensures the right content reaches the right audience at the right time. AI-driven solutions automate workflows and leverage data analytics to maximize reach and engagement.
Transforming the Content Supply Chain
To stay competitive, pharmaceutical companies must transform their content supply chain, addressing creation, review, and distribution while ensuring relevance and compliance. This transformation requires a comprehensive approach and often involves partnering with experts.
Moving Forward: The Future of Content Velocity
As the pharmaceutical industry evolves, so must its approach to content velocity. By embracing AI-driven solutions and refining workflows, brands can achieve a new standard in content delivery, ensuring compliance, efficiency, and greater impact in the marketplace.
Read Angela full article to learn more about mastering content velocity and setting a new benchmark for success in the industry.